Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48 USD | -3.87% | +0.99% | -19.85% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.85% | 6.02B | |
-2.86% | 87.31B | |
+2.63% | 40.86B | |
-21.44% | 29.36B | |
+58.56% | 24.49B | |
-14.37% | 17.31B | |
-18.67% | 11.62B | |
-15.61% | 11.31B | |
-44.02% | 11.26B | |
+5.17% | 8.31B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Goldman Sachs Adjusts Price Target on Apellis Pharmaceuticals to $102 From $91, Reiterates Buy Rating